Cancer-related direct-to-consumer advertising: Awareness, perceptions, and reported impact among patients undergoing active cancer treatment

Journal of Clinical Oncology

Volumn 27, Issue 25, 2009, Pages 4182-4187

  Abel, Gregory A ^a   Burstein, Harold J ^a   Hevelone, Nathanael D ^a   Weeks, Jane C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERTIZING; ARTICLE; AWARENESS; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; CONSUMER HEALTH INFORMATION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATICS; PERCEPTION; PRESCRIPTION; PRIORITY JOURNAL; TELEVISION; ATTITUDE TO HEALTH; BLOOD DISEASE; BREAST TUMOR; CLINICAL PRACTICE; COHORT ANALYSIS; DOCTOR PATIENT RELATION; DRUG INFORMATION; FINANCIAL MANAGEMENT; INFORMATION DISSEMINATION; MASS MEDIUM; MIDDLE AGED; PATIENT EDUCATION; PATIENT SATISFACTION; QUESTIONNAIRE;

ADVERTISING AS TOPIC; AWARENESS; BREAST NEOPLASMS; COHORT STUDIES; DRUG INFORMATION SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMATOLOGIC NEOPLASMS; HUMANS; INFORMATION DISSEMINATION; MALE; MARKETING OF HEALTH SERVICES; MASS MEDIA; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PERCEPTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES;

EID: 70249124260     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.6599     Document Type: Article

References (26)

1. Wilkes M, Bell R, Kravitz R: Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Aff (Millwood) 19:110-128, 2000
2. Donohue JM, Cevasco M, Rosenthal MB: A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 357:673-681, 2007
3. Kaphingst KA, DeJong W: The educational potential of direct-to-consumer prescription drug advertising. Health Aff (Millwood) 23:143-150, 2004
4. Robinson AR, Hohmann KB, Rifkin JI, et al: Direct-to-consumer pharmaceutical advertising: Physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med 164:427-432, 2004
5. Shuchman M: Drug risks and free speech: Can Congress ban consumer drug ads? N Engl J Med 356:2236-2239, 2007
6. Prescription drugs: Improvements needed in FDA's oversight of direct-to-consumer advertising, in US General Accountability Office (ed): Report to Congressional Requesters. Washington DC, US Government Accountability Office, 2006, pp 1-19
7. Baciu A, Stratton K, Burke S: The future of drug safety: Promoting and protecting the health of the public. Washington, DC, Committee on the Assessment of the US Drug Safety System Board on Population Health and Public Health Practice, Institute of Medicine, The National Academies Press, 2006
8. Abel GA, Lee SJ, Weeks JC: Direct-to-consumer advertising in oncology: A content analysis of print media. J Clin Oncol 25:1267-1271, 2007
9. Boden WE, Diamond GA: DTCA for PTCA: Crossing the line in consumer health education? N Engl J Med 358:2197-2200, 2008
10. Jagsi R: Conflicts of interest and the physician-patient relationship in the era of direct-to-patient advertising. J Clin Oncol 25:902-905, 2007
11. Groves R, Fowler F, Couper M, et al: Survey Methodology. Hoboken, NJ, Wiley-Interscience, 2004
12. Weisberg H, Krosnik J, Bowen B: An Introduction to Survey Research, Polling, and Data Analysis. Thousand Oaks, CA, Sage Publications, 1996
13. Weissman JS, Blumenthal D, Silk AJ, et al: Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (Millwood) W3-82-95, 2003 (suppl)
14. Consumer Assessment of Healthcare Providers and Systems Survey 3.0 (CAHPS). Rockville, MD, Agency for Healthcare Research and Quality, 2006
15. Health Information National Trends Survey (HINTS). Bethesda, MD, National Cancer Institute, 2005
16. Malin JL, Ko C, Ayanian JZ, et al: Understanding cancer patients' experience and outcomes: Development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 14:837-848, 2006
17. Bell RA, Kravitz RL, Wilkes MS: Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med 14:651-657, 1999
18. Four in 10 Americans Say They Have Trouble Paying for Drugs or Skip Prescriptions or Cut Pills Due to Cost. Harvard School of Public Health/Kaiser FamilyFoundation/USAToday. http://www.hsph.harvard. edu/news/press-releases/ 2008-releases/poll-usa-todaykaiser-harvard-prescription-drugs.html
19. Peyrot M, Alperstein NM, Van Doren D, et al: Direct-to-consumer ads can influence behavior: Advertising increases consumer knowledge and prescription drug requests. Mark Health Serv 18:26-32, 1998
20. Sumpradit N, Fors SW, McCormick L: Consumers' attitudes and behavior toward prescription drug advertising. Am J Health Behav 26:68-75, 2002
21. Viale PH, Sanchez Yamamoto D: The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications. Oncol Nurs Forum 31:777-783, 2004
22. Schommer JC, Singh RL, Hansen RA: Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Res Social Adm Pharm 1:231-250, 2005
23. Aikin K, Swasy J, Braman A: Patient and physician attitudes and behaviors associated with direct-to-consumer promotion of prescription drugs - summary of FDA survey research results, final report. Washington, DC, United States Food and Drug Administration, Division of Drug Marketing, Advertising, and Communications, 2004
24. Murray E, Lo B, Pollack L, et al: Direct-to-consumer advertising: Physicians' views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract 16:513-524, 2003
25. Hoek J, Maubach N: Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines. N Z Med J 120:U2425, 2007
26. Brekke KR, Kuhn M: Direct to consumer advertising in pharmaceutical markets. J Health Econ 25:102-130, 2006